• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗组胺药溴苯那敏对HERG钾通道的阻断需要通道与S6残基Y652和F656内结合。

Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656.

作者信息

Park Sang-Joon, Kim Ki-Suk, Kim Eun-Joo

机构信息

Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Yuseong, Daejeon, 305-600, Korea.

出版信息

J Appl Toxicol. 2008 Mar;28(2):104-11. doi: 10.1002/jat.1252.

DOI:10.1002/jat.1252
PMID:17516459
Abstract

A number of clinically used drugs block delayed rectifier K+ channels and prolong the duration of cardiac action potentials associated with long QT syndrome. This study investigated the molecular mechanisms of voltage-dependent inhibition of human ether-a-go-go-related gene (HERG) delayed rectifier K+ channels expressed in HEK-293 cells by brompheniramine, an antihistamine. Brompheniramine inhibited HERG current in a concentration-dependent manner with the half-maximal inhibitory concentration (IC50) value of 1.7 microm at 0 mV. A block of HERG current by brompheniramine was enhanced by progressive membrane depolarization and showed significantly negative shift in voltage-dependence of channel activation. Inhibition of HERG current by brompheniramine showed time-dependence. The S6 residue HERG mutant Y652A and F656C largely reduced the blocking potency of HERG current. These results indicate that brompheniramine mainly inhibited the HERG potassium channel through the residue Y652 and F656 and these residues may be an obligatory determinant in inhibition of HERG current for brompheniramine.

摘要

一些临床使用的药物会阻断延迟整流钾通道,并延长与长QT综合征相关的心脏动作电位的持续时间。本研究调查了抗组胺药溴苯那敏对人ether-a-go-go相关基因(HERG)延迟整流钾通道电压依赖性抑制的分子机制,该通道在HEK-293细胞中表达。溴苯那敏以浓度依赖性方式抑制HERG电流,在0 mV时半数最大抑制浓度(IC50)值为1.7微摩尔。膜电位逐渐去极化会增强溴苯那敏对HERG电流的阻断作用,且通道激活的电压依赖性出现明显负向偏移。溴苯那敏对HERG电流的抑制具有时间依赖性。HERG的S6残基突变体Y652A和F656C大大降低了对HERG电流的阻断效力。这些结果表明,溴苯那敏主要通过Y652和F656残基抑制HERG钾通道,这些残基可能是溴苯那敏抑制HERG电流的必要决定因素。

相似文献

1
Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656.抗组胺药溴苯那敏对HERG钾通道的阻断需要通道与S6残基Y652和F656内结合。
J Appl Toxicol. 2008 Mar;28(2):104-11. doi: 10.1002/jat.1252.
2
High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656.抗心律失常药物决奈达隆对HERG钾离子通道的高亲和力阻断作用:对S6残基Y652和F656突变的抗性
Biochem Biophys Res Commun. 2004 Dec 17;325(3):883-91. doi: 10.1016/j.bbrc.2004.10.127.
3
Inhibition of the HERG K+ channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656.抗真菌药物酮康唑对HERG钾通道的抑制作用取决于通道门控,并涉及S6残基F656。
FEBS Lett. 2006 Apr 3;580(8):1999-2005. doi: 10.1016/j.febslet.2006.02.073. Epub 2006 Mar 7.
4
Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.氯马斯汀,一种传统抗组胺药,是HERG钾通道的高效抑制剂。
J Mol Cell Cardiol. 2006 Jan;40(1):107-18. doi: 10.1016/j.yjmcc.2005.09.017. Epub 2005 Nov 9.
5
Effect of sibutramine HCl on cardiac hERG K+ channel.盐酸西布曲明对心脏人ether-à-go-go相关基因(hERG)钾通道的影响。
Mol Cell Biochem. 2009 Jan;320(1-2):125-31. doi: 10.1007/s11010-008-9914-2. Epub 2008 Sep 10.
6
Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.氟伏沙明对HERG钾电流的阻断作用:F656或Y652位点的S6突变不能完全减弱该作用
Br J Pharmacol. 2003 Jul;139(5):887-98. doi: 10.1038/sj.bjp.0705335.
7
Inhibition of cardiac HERG potassium channels by antidepressant maprotiline.抗抑郁药马普替林对心脏HERG钾通道的抑制作用。
Eur J Pharmacol. 2006 Feb 15;531(1-3):1-8. doi: 10.1016/j.ejphar.2005.10.036. Epub 2006 Jan 19.
8
Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain.人去极化激活延迟整流钾离子通道(hERG)通道阻滞的电压依赖性特征受S6跨膜结构域中单个残基的影响。
Mol Pharmacol. 2003 May;63(5):1051-8. doi: 10.1124/mol.63.5.1051.
9
Fluconazole inhibits hERG K(+) channel by direct block and disruption of protein trafficking.氟康唑通过直接阻断和蛋白转运破坏抑制 hERG K(+) 通道。
Eur J Pharmacol. 2011 Jan 10;650(1):138-44. doi: 10.1016/j.ejphar.2010.10.010. Epub 2010 Oct 15.
10
Papaverine, a vasodilator, blocks the pore of the HERG channel at submicromolar concentration.罂粟碱是一种血管舒张剂,在亚微摩尔浓度下可阻断HERG通道的孔隙。
J Cardiovasc Pharmacol. 2008 Dec;52(6):485-93. doi: 10.1097/FJC.0b013e31818e65c2.

引用本文的文献

1
Ensemble of structure and ligand-based classification models for hERG liability profiling.用于hERG风险评估的基于结构和配体的分类模型集成
Front Pharmacol. 2023 Mar 23;14:1148670. doi: 10.3389/fphar.2023.1148670. eCollection 2023.
2
The protease inhibitor atazanavir blocks hERG K(+) channels expressed in HEK293 cells and obstructs hERG protein transport to cell membrane.蛋白酶抑制剂阿扎那韦可阻断在人胚肾293(HEK293)细胞中表达的人醚-去极化激活的钾离子通道(hERG K(+)通道),并阻碍hERG蛋白转运至细胞膜。
Acta Pharmacol Sin. 2015 Apr;36(4):454-62. doi: 10.1038/aps.2014.165. Epub 2015 Mar 23.
3
Early identification of hERG liability in drug discovery programs by automated patch clamp.
通过自动化膜片钳技术在药物研发项目中早期鉴定 hERG 相关的致心律失常风险。
Front Pharmacol. 2014 Sep 2;5:203. doi: 10.3389/fphar.2014.00203. eCollection 2014.
4
Current use of domperidone and co-prescribing of medications that increase its arrhythmogenic potential among older adults: a population-based cohort study in Ontario, Canada.多潘立酮的当前使用情况以及老年人中增加其致心律失常风险的药物联合处方情况:加拿大安大略省一项基于人群的队列研究。
Drugs Aging. 2014 Nov;31(11):805-13. doi: 10.1007/s40266-014-0215-z.
5
Pharmacology of antihistamines.抗组胺药的药理学
Indian J Dermatol. 2013 May;58(3):219-24. doi: 10.4103/0019-5154.110832.
6
Pharmacology of antihistamines.抗组胺药的药理学。
World Allergy Organ J. 2011 Mar;4(3 Suppl):S22-7. doi: 10.1097/WOX.0b013e3181f385d9.
7
Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin.四环类抗抑郁药米安色林对心脏人乙醚相关基因钾通道的抑制作用。
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jul;378(1):73-83. doi: 10.1007/s00210-008-0289-4. Epub 2008 May 6.